Djibouti vs Sudan: Access to anti-retroviral drugs, female
Djibouti
23.0%
in 2024
Sudan
19.0%
in 2024
Djibouti rank
137th
Sudan rank
140th
Access to anti-retroviral drugs, female over time
- Djibouti
- Sudan
How they compare
Djibouti currently reports 23.0% against 19.0% in Sudan, a difference of 4.0%.
That makes Djibouti's figure about 1.2 times Sudan's.
The two have swapped places 5 times across 21 shared years of data; in 2000 it was Sudan ahead.
Djibouti ranks 137th and Sudan ranks 140th of 141 countries.
Djibouti has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Djibouti | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.3% | 1.8% | 0.5% | Djibouti |
| 2010s | 17.7% | 14.5% | 3.2% | Djibouti |
| 2020s | 23.8% | 23.4% | 0.4% | Djibouti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Djibouti or Sudan?
- Djibouti, at 23.0% against 19.0% in Sudan as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Djibouti and Sudan?
- 4.0%, with Djibouti ahead.
- How many years of comparable data are there for Djibouti and Sudan?
- 21 years are reported by both, from 2000 to 2024.
- How do Djibouti and Sudan rank globally for access to anti-retroviral drugs, female?
- Djibouti ranks 137th and Sudan ranks 140th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.